scholarly journals Utilizing electronic medical record data to predict onset of Alzheimer’s disease and related dementias

2020 ◽  
Vol 16 (S10) ◽  
Author(s):  
David E Marra ◽  
Amber H. Miller ◽  
Qian Li ◽  
Xi Yang ◽  
Glenn E. Smith ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Medical Record ◽  
Electronic Medical Record ◽  
Medical Record Data ◽  
Electronic Medical Record Data ◽  
Record Data

scholarly journals Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk

2016 ◽  
Vol 34 (6) ◽  
pp. 566-571 ◽  
Author(s):  
Kevin T. Nead ◽  
Greg Gaskin ◽  
Cariad Chester ◽  
Samuel Swisher-McClure ◽  
Joel T. Dudley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Propensity Score ◽  
Medical Record ◽  
Disease Risk ◽  
Medical Record Data ◽  
Electronic Medical Record Data ◽  
Increased Risk ◽  
Record Data

Purpose To test the association of androgen deprivation therapy (ADT) in the treatment of prostate cancer with subsequent Alzheimer’s disease risk. Methods We used a previously validated and implemented text-processing pipeline to analyze electronic medical record data in a retrospective cohort of patients at Stanford University and Mt. Sinai hospitals. Specifically, we extracted International Classification of Diseases-9th revision diagnosis and Current Procedural Terminology codes, medication lists, and positive-present mentions of drug and disease concepts from all clinical notes. We then tested the effect of ADT on risk of Alzheimer’s disease using 1:5 propensity score–matched and traditional multivariable-adjusted Cox proportional hazards models. The duration of ADT use was also tested for association with Alzheimer’s disease risk. Results There were 16,888 individuals with prostate cancer meeting all inclusion and exclusion criteria, with 2,397 (14.2%) receiving ADT during a median follow-up period of 2.7 years (interquartile range, 1.0-5.4 years). Propensity score–matched analysis (hazard ratio, 1.88; 95% CI, 1.10 to 3.20; P = .021) and traditional multivariable-adjusted Cox regression analysis (hazard ratio, 1.66; 95% CI, 1.05 to 2.64; P = .031) both supported a statistically significant association between ADT use and Alzheimer’s disease risk. We also observed a statistically significant increased risk of Alzheimer’s disease with increasing duration of ADT (P = .016). Conclusion Our results support an association between the use of ADT in the treatment of prostate cancer and an increased risk of Alzheimer’s disease in a general population cohort. This study demonstrates the utility of novel methods to analyze electronic medical record data to generate practice-based evidence.

scholarly journals Use of Electronic Medical Record Data for Quality Improvement in Schizophrenia Treatment

2004 ◽  
Vol 11 (5) ◽  
pp. 351-357 ◽  
Author(s):  
Richard R. Owen ◽  
Carol R. Thrush ◽  
Dale Cannon ◽  
Kevin L. Sloan ◽  
Geoff Curran ◽  
...  
Keyword(s):  
Quality Improvement ◽  
Medical Record ◽  
Electronic Medical Record ◽  
Medical Record Data ◽  
Electronic Medical Record Data ◽  
Record Data

Benchmarking Inpatient Mortality Using Electronic Medical Record Data

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Thomas L. Higgins ◽  
Laura Freeseman-Freeman ◽  
Maureen M. Stark ◽  
Kathy N. Henson
Keyword(s):  
Medical Record ◽  
Electronic Medical Record ◽  
Inpatient Mortality ◽  
Medical Record Data ◽  
Electronic Medical Record Data ◽  
Record Data
Sign in / Sign up

Export Citation Format

Share Document